| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-042 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 第三届监事会第六次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于全资 子公司购买资产暨关联交易的公告》（公告编号：2025-043）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。本议案获得通过。 三、备查文件 1 第三届监事会第六次会议决议。 湖北共同药业股份有限公司（以下简称"公司"）第三届监事会第六次会议于 2025 年 8 月 5 日在公司会议室以现场结合通讯表决的方式召开。会议通知及材料于 2025 年 7 月 25 日以电话、微信等通讯的方式送达。会议由公司监事会主席蒋建军主 持，会议应到监事 3 人，实际参会监事 3 人。 会议的召开符合《中华人民共和国公司法》《湖北共同药业股份有限公司章程》 《湖北共同药业 ...

| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-041 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 第三届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖北共同药业股份有限公司（以下简称"公司"）第三届董事会第七次会议于 2025 年 8 月 5 日在公司会议室以现场结合通讯表决的方式召开。会议通知及材料于 2025 年 7 月 25 日以电话、微信等通讯方式送达。会议由公司董事长系祖斌主持，会 议应到董事 7 人，实际参会董事 7 人，独立董事龙子午、祁飞、何德良以通讯表决 方式出席会议。公司高级管理人员列席了本次会议。 本议案在提交公司董事会审议前已经公司独立董事专门会议审议通过。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于全资 子公司购买资产暨关联交易的公告》（公告编号：2025-043）。 关联董事系祖斌回避表决，其余 6 名董事参与了表决。 本次会 ...

Group 1 - The assisted reproductive concept sector declined by 1.60%, ranking among the top declines in concept sectors, with leading decliners including Lide Man, Hanyu Pharmaceutical, and Gongtong Pharmaceutical [1] - Among the 14 stocks that increased in price, Hc Pharma, Madi Technology, and Bei Yin Mei saw gains of 4.24%, 3.36%, and 3.25% respectively [1] - The assisted reproductive sector experienced a net outflow of 1.895 billion yuan, with 57 stocks facing net outflows, and 12 stocks seeing outflows exceeding 50 million yuan [1] Group 2 - The top net outflow stock was Hanyu Pharmaceutical, with a net outflow of 256 million yuan, followed by Guangsheng Tang, Anke Biological, and Zhongsheng Pharmaceutical with net outflows of 189 million yuan, 149 million yuan, and 129 million yuan respectively [2] - The stocks with the highest net inflows included Hc Pharma, Bei Yin Mei, and Puni Testing, with net inflows of 48.48 million yuan, 35.29 million yuan, and 24.35 million yuan respectively [1][4]

天眼查商业履历信息显示，湖北共同药业股份有限公司，成立于2006年，位于襄阳市，是一家以从事医 药制造业为主的企业。企业注册资本11527.7万人民币，实缴资本6900.21万人民币。公司法定代表人为 系祖斌。 通过天眼查大数据分析，湖北共同药业股份有限公司共对外投资了7家企业，参与招投标项目15次，知 识产权方面有商标信息5条，专利信息59条，此外企业还拥有行政许可293个。 来源：金融界 金融界消息 截至2025年8月5日收盘，共同药业（300966）报收于26.85元，下跌5.22%，换手率 25.45%，成交量19.51万手，成交金额5.16亿元。 资金流向方面，今日主力资金净流出3104.24万元，占比成交额6.01%。其中，超大单净流出580.55万 元、占成交额1.12%，大单净流出2523.69万元、占成交额4.89%，中单净流出流入980.60万元、占成交 额1.9%，小单净流入2123.64万元、占成交额4.11%。 共同药业最新一期业绩显示，截至2025一季报，公司营业总收入1.39亿元、同比增长13.90%，归属净利 润108.21万元，同比减少69.50%，扣非净利润133.66万元 ...

New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]

Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]

Group 1 - The stock of Hubei Gongtong Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from July 30 to August 1, 2025 [1] - The company's board of directors conducted a verification regarding the abnormal trading situation and confirmed that there are no undisclosed significant information or major matters under planning that could affect the stock price [1][1] - The board also stated that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require correction or supplementation [1][1]

Market Overview - As of August 1, the Shanghai Composite Index closed at 3559.95 points, with a decline of 0.37%. The Shenzhen Component Index closed at 10991.32 points, down 0.17%, and the ChiNext Index closed at 2322.63 points, decreasing by 0.24% [1]. Trading Volume Analysis - A total of 1503 stocks saw an increase in average transaction volume, with 31 stocks experiencing a rise of over 50%. Conversely, 3051 stocks reported a decrease in average transaction volume [1]. - Notable stocks with significant increases in average transaction volume include Kecuan Technology, Shenghui Integration, and Zhengzhong Design [1]. Active Stocks by Transaction Volume - The stocks with the highest increase in average transaction volume on August 1 include: - Kecuan Technology: 9.99% increase, average transaction volume of 1014 shares, up 193.10% [3]. - Shenghui Integration: 10.00% increase, average transaction volume of 672 shares, up 191.70% [3]. - Zhengzhong Design: 10.00% increase, average transaction volume of 2134 shares, up 168.74% [3]. Active Stocks by Transaction Count - The stocks with the highest increase in transaction count on August 1 include: - Anzheng Fashion: -1.69% change, with 68,433 transactions, up 1618.56% [2]. - Yingweike: 2.04% change, with 218,079 transactions, up 1082.38% [2]. - Zhongjiabo Chuang: -3.90% change, with 48,487 transactions, up 656.19% [2]. Stocks with Significant Increases in Both Volume and Count - Kecuan Technology stands out with a 9.99% increase, an average transaction volume of 1014 shares (up 193.10%), and a transaction count of 16,921 (up 126.52%) [4]. - Other notable stocks include: - Jiejia Weichuang: 20.00% increase, average transaction volume of 838 shares (up 130.45%), and 57,709 transactions (up 121.19%) [4]. - Riyi Electronics: 10.01% increase, average transaction volume of 846 shares (up 113.00%), and 25,112 transactions (up 161.72%) [4].

Group 1 - The company announced a share buyback program, having repurchased a total of 197,500 shares as of July 31, 2025, which represents 0.17% of its current total share capital [1]

共同药业8月1日交易公开信息 | 买/ 卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 招商证券股份有限公司银川北京中路证券营业部 | 1890.37 | 0.00 | | 买二 | 东方财富证券股份有限公司拉萨东环路第二证券营业 | 859.78 | 568.59 | | | 部 | | | | 买三 | 东方财富证券股份有限公司拉萨团结路第二证券营业 | 790.87 | 988.54 | | | 部 | | | | 买四 | 东方财富证券股份有限公司拉萨东环路第一证券营业 | 764.44 | 182.67 | | | 部 | | | | 买五 | 东方财富证券股份有限公司拉萨团结路第一证券营业 | 752.91 | 159.50 | | | 部 | | | | 卖一 | 国信证券股份有限公司北京分公司 | 91.37 | 4336.79 | | 卖二 | 华鑫证券有限责任公司上海陆家嘴证券营业部 | 3.87 | 3545.11 | | 卖三 | 开源证券股份有限公司西安西大街证券营业部 | 1.95 | 276 ...